Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1369970 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
A novel class of Hsp90 inhibitors, structurally distinct from previously reported scaffolds, was developed from rational design and optimization of a compound library screen hit. These aminoquinazoline derivatives, represented by compound 15 (SNX-6833) or 1-(2-amino-4-methylquinazolin-7-yl)-3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one, selectively bind to Hsp90 and inhibit its cellular activities at concentrations as low as single digit nanomolar.
Graphical abstractCompound affinity to Hsp90 in Kd and cellular activities in IC50.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Kenneth H. Huang, Thomas E. Barta, John W. Rice, Emilie D. Smith, Andy J. Ommen, Wei Ma, James M. Veal, R. Patrick Fadden, Amy F. Barabasz, Briana E. Foley, Philip F. Hughes, Gunnar J. Hanson, Christopher J. Markworth, Melanie Silinski,